Company research / ADVB

Advanced Biomed Inc. (ADVB)

CIK 0001941029 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated NV
  • Fiscal year ends Jun 30

Partial revenue. In this company's filings, net income for the year ended 2026-06-30 is larger than reported revenue. The revenue it tags covers only part of its income (banks and REITs often tag only fee income this way, leaving out interest or rent), so it is not the company's whole top line. Margins on it are not computed, and it is left out of revenue rankings.

Key ratios (year ended 2026-06-30)

54.4%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-K (annual report) · 2026-10-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Stock splits: 1-for-20, first reflected in a filing dated 2026-05-15. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView